Literature DB >> 20448306

Putative neuroprotective effects of caffeine in clinical trials. Concluding remarks.

Alexandre de Mendonça1, Rodrigo A Cunha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20448306     DOI： 10.3233/JAD-2010-01411

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN： 1387-2877            Impact factor:   4.472


× No keyword cloud information.
  5 in total

Review 1.  The role of phytochemicals in the treatment and prevention of dementia.

Authors:  Melanie-Jayne R Howes; Elaine Perry
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

2.  Coffee, but not caffeine, has positive effects on cognition and psychomotor behavior in aging.

Authors:  Barbara Shukitt-Hale; Marshall G Miller; Yi-Fang Chu; Barbara J Lyle; James A Joseph
Journal:  Age (Dordr)       Date:  2013-01-24

3.  Coffee intake in midlife and risk of dementia and its neuropathologic correlates.

Authors:  Rebecca P Gelber; Helen Petrovitch; Kamal H Masaki; G Webster Ross; Lon R White
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  Neuromodulation and neuroprotective effects of chlorogenic acids in excitatory synapses of mouse hippocampal slices.

Authors:  Mara Yone D Fernandes; Fernando Dobrachinski; Henrique B Silva; João Pedro Lopes; Francisco Q Gonçalves; Felix A A Soares; Lisiane O Porciúncula; Geanne M Andrade; Rodrigo A Cunha; Angelo R Tomé
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

Review 5.  Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors.

Authors:  Ana M Sebastião; Nádia Rei; Joaquim A Ribeiro
Journal:  Front Pharmacol       Date:  2018-04-16       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.